rs3217319
Positions:
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP6_ModerateBA1
The NM_144684.4(ZNF480):βc.9_10delβ(p.Cys3Ter) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.713 in 1,612,698 control chromosomes in the GnomAD database, including 415,545 homozygotes. Variant has been reported in ClinVar as Benign (β ).
Frequency
Genomes: π 0.63 ( 31645 hom., cov: 0)
Exomes π: 0.72 ( 383900 hom. )
Consequence
ZNF480
NM_144684.4 frameshift
NM_144684.4 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: -0.0310
Genes affected
ZNF480 (HGNC:23305): (zinc finger protein 480) Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Located in cytosol and nucleoplasm. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -10 ACMG points.
BP6
Variant 19-52300416-CTG-C is Benign according to our data. Variant chr19-52300416-CTG-C is described in ClinVar as [Benign]. Clinvar id is 403625.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.728 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ZNF480 | NM_144684.4 | c.9_10del | p.Cys3Ter | frameshift_variant | 2/5 | ENST00000595962.6 | NP_653285.2 | |
ZNF480 | NM_001297624.2 | c.9_10del | p.Cys3Ter | frameshift_variant | 2/4 | NP_001284553.1 | ||
ZNF480 | NM_001297625.2 | c.-96_-95del | 5_prime_UTR_variant | 2/4 | NP_001284554.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZNF480 | ENST00000595962.6 | c.9_10del | p.Cys3Ter | frameshift_variant | 2/5 | 1 | NM_144684.4 | ENSP00000471754 | P1 |
Frequencies
GnomAD3 genomes AF: 0.629 AC: 95257AN: 151508Hom.: 31650 Cov.: 0
GnomAD3 genomes
AF:
AC:
95257
AN:
151508
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.691 AC: 173530AN: 251220Hom.: 61168 AF XY: 0.701 AC XY: 95241AN XY: 135790
GnomAD3 exomes
AF:
AC:
173530
AN:
251220
Hom.:
AF XY:
AC XY:
95241
AN XY:
135790
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.722 AC: 1054817AN: 1461072Hom.: 383900 AF XY: 0.722 AC XY: 525143AN XY: 726888
GnomAD4 exome
AF:
AC:
1054817
AN:
1461072
Hom.:
AF XY:
AC XY:
525143
AN XY:
726888
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.628 AC: 95265AN: 151626Hom.: 31645 Cov.: 0 AF XY: 0.634 AC XY: 46961AN XY: 74060
GnomAD4 genome
AF:
AC:
95265
AN:
151626
Hom.:
Cov.:
0
AF XY:
AC XY:
46961
AN XY:
74060
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2193
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Mar 29, 2016 | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency in ESP (all): 7679/12518=61.35% - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at